Authors' reply to Selvapatt and colleagues, Matthews and colleagues, Badrinath, and Ward and Lee

Affiliations

Comment

Ronald L Koretz et al. BMJ. 2015.

. 2015 Feb 24:350:h674.

doi: 10.1136/bmj.h674.

No abstract available

Comment on

Is widespread screening for hepatitis C justified?
Koretz RL, Lin KW, Ioannidis JP, Lenzer J. Koretz RL, et al. BMJ. 2015 Jan 13;350:g7809. doi: 10.1136/bmj.g7809. BMJ. 2015. PMID: 25587052 No abstract available.
Early diagnosis and treatment: the goal of hepatitis C screening.
Selvapatt N, Brown A, Thursz M. Selvapatt N, et al. BMJ. 2015 Feb 24;350:h635. doi: 10.1136/bmj.h635. BMJ. 2015. PMID: 25711892 No abstract available.
NICE's recommendation on sofosbuvir for hepatitis C.
Badrinath P. Badrinath P. BMJ. 2015 Feb 24;350:h637. doi: 10.1136/bmj.h637. BMJ. 2015. PMID: 25711893 No abstract available.
Hepatitis C screening of men who have sex with men.
Ward CJ, Lee V. Ward CJ, et al. BMJ. 2015 Feb 24;350:h642. doi: 10.1136/bmj.h642. BMJ. 2015. PMID: 25711894 No abstract available.
Screening and treatment for hepatitis C: a balanced perspective.
Matthews PC, Jeffery K, Klenerman P, Barnes E, Cooke G. Matthews PC, et al. BMJ. 2015 Feb 24;350:h644. doi: 10.1136/bmj.h644. BMJ. 2015. PMID: 25711895 No abstract available.